Mevo
Mevo is a Brazilian healthtech operating a digital prescription platform integrated into 1,100+ healthcare institutions and 7 major insurance providers covering ~30% of Brazil's private market, complemented by an online pharmacy (Mevo Farma) and pharmacy dispensing module serving patients, providers, and insurers.
- Company typePrivate
- Founded2017
- HeadquartersSão Paulo, Brazil
- Headcount51–100
- GTM typeB2B and B2C
- OfferingSoftware
What Mevo does
Mevo is a Brazilian healthtech company founded in 2017 and headquartered in São Paulo that operates a digital prescription and online pharmacy platform. The company addresses structural inefficiencies in Brazil's healthcare system, where roughly 150 million people manage approximately one billion handwritten prescriptions annually. Its core product, Mevo Receita Digital, enables healthcare providers to issue electronic prescriptions delivered to patients via SMS or WhatsApp, replacing paper-based workflows. The platform is integrated into more than 1,100 healthcare institutions and connected to seven major health insurance providers representing approximately 30% of Brazil's private healthcare market.
Beyond digital prescriptions, Mevo extends its ecosystem through Mevo Farma, an online pharmacy enabling patients to purchase medications digitally with home delivery, and Mevo Dispensação, a pharmacy-side module for verifying and dispensing digital prescriptions. Together these products span the connected patient journey—consultation, prescription issuance, exam scheduling, fulfillment, and dispensing. The April 2025 acquisition of Receita Digital further consolidated the provider-side footprint and prescription issuance capabilities.
Mevo's business model combines B2B platform revenue from healthcare institutions and insurance providers with transaction-based revenue from its online pharmacy (Mevo Farma). Its go-to-market is sales-led, relying on direct enterprise partnerships with hospitals, clinics, telemedicine platforms, and health insurers; on the consumer side, patients receive digital prescriptions and can purchase medications online, subject to Brazilian controlled-substance regulations (Portaria 344). The company has raised approximately R$340 million (~$68M USD) in cumulative funding across multiple rounds, with a March 2026 round led by Prosus.
Mevo firmographics
Firmographics- Name
- Mevo
- Legal name
- Mevo
- Website
- https://mevosaude.com.br
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Mevo is a Brazilian healthtech operating a digital prescription platform integrated into 1,100+ healthcare institutions and 7 major insurance providers covering ~30% of Brazil's private market, complemented by an online pharmacy (Mevo Farma) and pharmacy dispensing module serving patients, providers, and insurers.
- Ownership category
- akta.pro rank
Mevo industry classification
Industry- Product category
- Digital Health Platform
- NAICS
- Pharmacies and Drug Retailers (456110), Ambulatory Health Care Services (621)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Virtual Pharmacy & Medication Management Integration Platforms (HLALABAL)
- akta.pro secondary industries
- DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription) (HLALAIAA), Pharmacy/Medication Management & Virtual MTM (Payer-Sponsored) (HLALACAK)
Keywords
Where Mevo is headquartered
LocationHeadquarters
- HQ city
- São Paulo
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
Mevo business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Digital Prescription Services: Revenue generated from healthcare institutions and providers using Mevo's digital prescription platform. The platform serves as an entry point for a connected patient journey including exam scheduling, patient support programs, and online medication fulfillment.
- Online Pharmacy (Mevo Farma): Transaction-based revenue from online medication sales and delivery services, allowing patients to purchase prescription medications digitally and receive them at their preferred location
Go-to-market motion1 record
Distribution channels4 records
Marketing channels2 records
Mevo product offering
Product offeringCore offering
Mevo operates a digital prescription (e-prescription) SaaS platform that enables Brazilian healthcare professionals to issue electronic prescriptions delivered to patients via SMS or WhatsApp, replacing handwritten prescriptions. The platform is supplemented by Mevo Farma, an online pharmacy for direct medication purchase and home delivery, and Mevo Dispensação, a pharmacy-side solution for verifying and dispensing digital prescriptions. Together they form an integrated ecosystem connecting 1,100+ healthcare institutions, 7 major health insurers, pharmacies, and patients across Brazil.
Product overview
Mevo is a Brazilian digital health platform offering an integrated ecosystem of healthcare solutions. The core offering is the Mevo Receita Digital platform for issuing and managing electronic medical prescriptions, which serves as the entry point for a connected patient journey. This core platform is supplemented by Mevo Farma (for online medication purchasing and delivery) and Mevo Dispensação (for pharmacy dispensing). The platform is integrated into over 1,100 healthcare institutions and connects patients, healthcare providers, hospitals, clinics, telemedicine services, and pharmacies across Brazil, with coverage through seven major health insurance providers representing approximately 30% of Brazil's private healthcare market.
Differentiator
Problem solved
Functional benefit
Brands
- Mevo Receita Digital: Digital prescription platform enabling healthcare providers to issue electronic prescriptions, and patients to receive prescriptions via SMS or WhatsApp.
- Mevo Farma
Products and services
- Mevo Receita Digital
Quantifiable outcome
- 20 million patients projected to be treated via digital prescriptions in 2026
- +2 more outcomes
Companies that use Mevo
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
Mevo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Mevo partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- Healthcare Institutions (1,100+)corePartner hospitals, clinics, and healthcare providers integrated into Mevo's digital prescription platform across Brazil.
- Health Insurance Providers (7 major)coreSeven major health insurance providers covering approximately 30% of Brazil's private healthcare market, integrated with Mevo's platform.
- Telemedicine PlatformscoreTelemedicine platforms integrated with Mevo's digital prescription system enabling remote healthcare consultations.
- Pharmacy PartnerscorePartner pharmacies that dispense medications using Mevo's digital prescription verification system.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
Mevo competitors and assessment
Company assessmentEmerging players
- Sami: Sami is a Brazilian healthtech offering a vertically integrated health plan with digital care delivery. It overlaps with Mevo in building connected patient journeys and digital prescription for its members.
- Alice: Alice is a Brazilian health plan with a strong digital-first care experience, including telemedicine and prescription management — a comparable end-to-end digital care model to Mevo's integrated ecosystem.
- Hims & Hers Health: Hims & Hers is a US DTC telehealth company with an integrated online pharmacy. It mirrors Mevo Farma's cash-pay, subscription-enabled online pharmacy model combined with tele-prescribing.
Broad incumbents
- GoodRx: GoodRx is a US prescription price-transparency and online pharmacy platform. Its model of routing digital prescriptions into a captive pharmacy network parallels Mevo Receita Digital + Mevo Farma at a larger, mature scale.
- Pague Menos: Pague Menos is a major Brazilian pharmacy chain with growing e-commerce and digital health ambitions, comparable to Mevo Farma on the medication delivery side of the value chain.
- DASA: DASA is Brazil's largest medical diagnostics company with integrated digital health services. It overlaps with Mevo in connected patient journeys (exams, prescriptions) for private healthcare consumers.
- Raia Drogasil (RD): RD is Brazil's largest pharmacy retail chain with its own digital platforms and customer base. It is a broad incumbent that competes with Mevo Farma on medication fulfillment and could build competing e-prescription rails.
Direct peers
- Memed: Memed is Brazil's other leading digital prescription platform, directly competing with Mevo Receita Digital by digitising handwritten prescriptions and connecting prescribers, patients and pharmacies across the country.
- Conexa Saúde: Conexa Saúde is a Brazilian telehealth and integrated care platform with overlapping use cases in teleconsultation, e-prescription and patient journey management, competing with Mevo's provider-integrated model.
- Portal Telemedicina: Portal Telemedicina operates a Brazilian telemedicine and digital diagnostics platform that issues prescriptions and exam orders remotely, overlapping with Mevo's prescription and exam-scheduling workflows.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Mevo social profiles
Digital presenceMevo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mevo leadership team
Management profileNumber of profiles
Profiles1 record
Mevo funding detail
Funding detailFunding overview
Funding rounds4 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mevo M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mevo
What does Mevo do?
Mevo operates a digital prescription (e-prescription) SaaS platform that enables Brazilian healthcare professionals to issue electronic prescriptions delivered to patients via SMS or WhatsApp, replacing handwritten prescriptions. The platform is supplemented by Mevo Farma, an online pharmacy for direct medication purchase and home delivery, and Mevo Dispensação, a pharmacy-side solution for verifying and dispensing digital prescriptions. Together they form an integrated ecosystem connecting 1,100+ healthcare institutions, 7 major health insurers, pharmacies, and patients across Brazil.
Is Mevo a public or private company?
Mevo is a private company. It is classified as venture growth investor backed and is currently operating.
When was Mevo founded?
Mevo was founded in 2017. It employs 51 to 100 people.
Where is Mevo based?
Mevo is headquartered in São Paulo, Brazil, in the Latin America region.
How does Mevo make money?
Two revenue lines are on record. Digital Prescription Services are the primary driver. The others are online Pharmacy (Mevo Farma).
Who are Mevo's main competitors?
Emerging players on record are Sami, Alice and Hims & Hers Health. Broad incumbents are GoodRx, Pague Menos, DASA and Raia Drogasil (RD). Direct peers are Memed, Conexa Saúde and Portal Telemedicina.
Does Mevo have an API?
No public API is recorded for Mevo.
What industry is Mevo in?
Mevo's product category is Digital Health Platform. Its primary akta.pro industry code is HLALABAL, Virtual Pharmacy & Medication Management Integration Platforms, with a secondary code of HLALAIAA, DTC Telehealth with Integrated Online Pharmacy (Cash-Pay/Subscription). Its NAICS code is 456110 and its SIC code is 5912.